ALMR Alamar Biosciences, Inc.
P/E
--
Forward P/E
--
Price/Sales
21.21
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Alamar Biosciences beats third quarter 2026 estimates and raises full-year revenue guidance
Alamar Biosciences reported total revenue of $33.5 million for the third quarter of 2026, representing a 68% year-over-year increase and exceeding analyst...
Alamar Biosciences, Inc. Q3 2026 Earnings Preview: What Analysts Expect on November 03, 2026
Alamar Biosciences is expected to report Q3 2026 revenue of $30.19 million and a loss of $0.22 per share, with its current stock price of $30.60 trading near...